THE DIRECTOR of Neurology and the Memory and Aging Program at Butler Hospital in Providence, Stephen Salloway, M.D., M.S., is also a professor of clinical neurosciences and psychiatry at the Warren Alpert Medical School at Brown University.
He is the director of the Brown Combined Residency in Neurology and Psychiatry and co-director of the Brown Dementia Research Fellowship Program, sponsored by the National Institute on Aging. He received his M.D. from Stanford Medical School and completed neurology and psychiatry residencies at Yale University.
Dr. Salloway has published more than 185 scientific articles, book chapters, and abstracts. His research focuses on: clinical trials for Alzheimer’s prevention and treatment, mild cognitive impairment, and vascular dementia; studies of genetic and sporadic forms of microvascular brain disease; studies of executive function and frontal behaviors; and the development of imaging biomarkers to study conversion to dementia. Dr. Salloway has received numerous research grants from the National Institutes of Health and from private foundations, including the Norman and Rosalie Fain Family Foundation. He published the first controlled clinical trials of cholinesterase inhibitors for the treatment of mild cognitive impairment and vascular dementia. Under his direction, the Butler Memory and Aging Program has become a nationally recognized clinical research center that tests new disease-modifying treatments for Alzheimer’s, including amyloid vaccines, gamma secretase inhibitors and modulators, antifibrillization agents, and RAGE inhibitors.
Dr. Salloway is a past president of the American Neuropsychiatric Association, a fellow of the American Academy of Neurology, and a member of the American Neurological Association.
He is a scientific reviewer for the National Institutes of Health and for more than 30 journals, universities, and research foundations. Salloway lectures widely on dementia.
